Product overview
Type
Diphtheria-Tetanus-Pertussis (whole cell)-Haemophilus influenzae type b
Commercial Name
Diphtheria, Tetanus, Pertussis and Haemophilus influenzae type b Conjugate Vaccine
Manufacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with liquid active component before use
Presentation
Vial + Ampoule
Number of Doses
1
Diluent
Liquid active component
Route of Administration
Intramuscular
Shelf Life
24 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
Carton (containing 4x50=200 vials of Hib component [Dimensions 18.5x9.5x6.0] and 4x50=200 ampoules of DTP component) [Dimensions 14.5x6.0x7.0] OR single dose carton (containing 1 vial of Hib component and one ampoule of DTP component)
Tertiary Packaging
Box of 16 carton of 50 vials of Hib component (800 vials/800 doses) and 16 cartons of 50 ampoules of DTP component (800 ampoules/800 doses) [Dimensions 60x48x41cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.005%
Cold Chain Volume
a. 21.09 (vial); b.12.18(ampoule) cm3/dose (in secondary packaging)
Attachments
